采用标准化 12 色流式细胞术评估 B 细胞前体急性淋巴细胞白血病 CD19 靶向治疗后的微小残留病:一项 EuroFlow 研究 Minimal residual disease assessment following CD19-targeted therapy in B-cell precursor acute lymphoblastic leukemia using standardized 12-color flow PubMed 2025/04/13 发表HemasphereQ1 · IF 11.3(JCR 2025) 靶点:CD19靶点:CD22靶点:CD7急性淋巴细胞白血病地区:欧洲